About ICC Melanoma 2020
HOW TO MANAGE TOXICITY AND ASSESS THE ANSWER TO IMMUNOTHERAPY IN MELANOMA PATIENTS
The immunological therapy of melanoma is going through a phase of great evolution, thanks to the important results obtained in many clinical studies, starting from 2010, following the introduction of antibodies against immunological checkpoints such as CTLA-4 and, in particular, PD -1. The purpose of this project is to investigate the main scenarios of difficult management of melanoma patients treated with ant-PD-1 antibodies, through examples of interactive clinical situations.
Similar Apps
AppMed
The official AccMed App
Give Me 5 Lite - Hand hygiene
Train health professionals on the importance of good hand hygiene practice.
Give Me 5 - Hand hygiene
Train health professionals on the importance of good hand hygiene practice.
Disostruzione delle vie aeree
The unblocking of the airway in infants and in children
